These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10491370)

  • 1. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.
    Tuomainen TP; Kontula K; Nyyssönen K; Lakka TA; Heliö T; Salonen JT
    Circulation; 1999 Sep; 100(12):1274-9. PubMed ID: 10491370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls.
    Sánchez M; Bruguera M; Bosch J; Rodés J; Ballesta F; Oliva R
    J Hepatol; 1998 Nov; 29(5):725-8. PubMed ID: 9833909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study.
    Rasmussen ML; Folsom AR; Catellier DJ; Tsai MY; Garg U; Eckfeldt JH
    Atherosclerosis; 2001 Feb; 154(3):739-46. PubMed ID: 11257277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
    Meier P; Schuff-Werner P; Steiner M
    Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study.
    Claeys D; Walting M; Julmy F; Wuillemin WA; Meyer BJ
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():3-8. PubMed ID: 11886425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans.
    Monaghan KG; Rybicki BA; Shurafa M; Feldman GL
    Am J Hematol; 1998 Jul; 58(3):213-7. PubMed ID: 9662273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation.
    Macdonald GA; Tarish J; Whitehall VJ; McCann SJ; Mellick GD; Buttenshaw RL; Johnson AG; Young J; Leggett BA
    J Gastroenterol Hepatol; 1999 Dec; 14(12):1188-91. PubMed ID: 10634155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patients.
    Swinkels DW; Venselaar H; Wiegerinck ET; Bakker E; Joosten I; Jaspers CA; Vasmel WL; Breuning MH
    Blood Cells Mol Dis; 2008; 40(3):334-8. PubMed ID: 18042412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of myocardial infarction in carriers of mutations in the hemochromatosis-associated gene.
    Margaglione M; Di Castelnuovo A; Totaro A; Iacoviello L; Di Minno G
    Thromb Haemost; 2000 Oct; 84(4):726-7. PubMed ID: 11057879
    [No Abstract]   [Full Text] [Related]  

  • 10. C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction.
    Annichino-Bizzacchi JM; Saad ST; Arruda VR; Ramires JA; Siqueira LH; Chiaparini LC; Mansur AP
    J Cardiovasc Risk; 2000 Feb; 7(1):37-40. PubMed ID: 10785872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women.
    Roest M; van der Schouw YT; de Valk B; Marx JJ; Tempelman MJ; de Groot PG; Sixma JJ; Banga JD
    Circulation; 1999 Sep; 100(12):1268-73. PubMed ID: 10491369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis.
    Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC
    Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic hemochromatosis with the mutation of Ala176Val heterozygous for HFE gene.
    Imanishi H; Liu W; Cheng J; Ikeda N; Amuro Y; Hada T
    Intern Med; 2001 Jun; 40(6):479-83. PubMed ID: 11446670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE gene mutations in coronary atherothrombotic disease.
    Calado RT; Franco RF; Pazin-Filho A; Simões MV; Marin-Neto JA; Zago MA
    Braz J Med Biol Res; 2000 Mar; 33(3):301-6. PubMed ID: 10719381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of hemochromatosis due to a new compound heterozygosity in HFE (p.[Gly43Asp;His63Asp]+[Cys282Tyr]): structural implications with respect to binding with transferrin receptor 1.
    Dupradeau FY; Pissard S; Coulhon MP; Cadet E; Foulon K; Fourcade C; Goossens M; Case DA; Rochette J
    Hum Mutat; 2008 Jan; 29(1):206. PubMed ID: 18157833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.
    Datz C; Lalloz MR; Vogel W; Graziadei I; Hackl F; Vautier G; Layton DM; Maier-Dobersberger T; Ferenci P; Penner E; Sandhofer F; Bomford A; Paulweber B
    J Hepatol; 1997 Nov; 27(5):773-9. PubMed ID: 9382962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases.
    Hetet G; Elbaz A; Gariepy J; Nicaud V; Arveiler D; Morrison C; Kee F; Evans A; Simon A; Amarenco P; Cambien F; Grandchamp B
    Eur J Clin Invest; 2001 May; 31(5):382-8. PubMed ID: 11380589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemochromatosis (HFE) genotype and atherosclerosis: Increased susceptibility to iron-induced vascular damage in C282Y carriers?
    Engberink MF; Povel CM; Durga J; Swinkels DW; de Kort WL; Schouten EG; Verhoef P; Geleijnse JM
    Atherosclerosis; 2010 Aug; 211(2):520-5. PubMed ID: 20400082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.